Skip to content

Postoperative Analgesic Efficacy of Recto Intercostal Nerve Block

Postoperative Analgesic Efficacy of Rectointercostal Nerve Block in Patients Undergoing Laparoscopic Cholecystectomy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07003698
Enrollment
60
Registered
2025-06-04
Start date
2025-06-22
Completion date
2026-04-28
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoskopic Cholecystectomy, Recto Intercostal Nerve Block

Keywords

Remifantanile conception, Acute pain, Postoperatif pain

Brief summary

Laparoscopic cholecystectomy is a frequently performed surgery and the gold standard for the treatment of symptomatic gallstone disease. Although laparoscopic cholecystectomy is considered minimally invasive, it can cause moderate to severe pain in the postoperative period. Poorly controlled early postoperative pain impairs recovery quality and increases the risk of postoperative pulmonary complications, serving as a risk factor for chronic pain development. Multimodal analgesia, including opioids, is used to manage pain following laparoscopic cholecystectomy. However, opioid treatment may lead to side effects such as postoperative nausea and vomiting (PONV), respiratory depression, and constipation. The primary aim of this study is to evaluate the effect of recto-intercostal nerve block as part of multimodal analgesia on intraoperative opioid consumption and postoperative pain scores in patients undergoing laparoscopic cholecystectomy.

Interventions

PROCEDUREThe group without the rectointercostal nerve block

Patients in this group will be administered dexketoprofen 50 mg and tramadol 100 mg intravenously in the intraoperative period. These patients will not receive the rectointercostal nerve block.

PROCEDUREThe rectointercostal plane block

The rectointercostal plane block is performed under ultrasound guidance before the surgical procedure and anesthesia induction, with the patient in the supine position. Additionally, patients in this group will be administered dexketoprofen 50 mg and tramadol 100 mg intravenously in the intraoperative period.

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 65 years old * American Society of Anesthesiologists (ASA) physical status I-II-III * Elective laparoscopic cholecystectomy surgery

Exclusion criteria

* Under 18 and over 65 years old * ASA score IV and above * Advanced co-morbidity * History of bleeding diathesis * Patient refusing the procedure * Chronic opioid or analgesic use * Patients who will operate under emergency conditions * Block injection site infection * Known allergy to local anesthetics * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative remifentanil consumptionDuring the intraoperative periodThe amount of remifentanil that patients need to maintain anesthesia during the intraoperative period will be recorded

Secondary

MeasureTime frameDescription
Pain scoresFirst 24 hours after surgeryPain will be assessed at rest and while movement using the from 0 (no pain) to 10 (worst)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026